Chemir Analytical Services has named Lawrence (Bob) R. Lima III, Ph.D., vice president of Pharmaceutical Services. Dr. Lima directs the drug development services of Chemir’s Maryland Heights facility.

“The pharmaceutical and medical device industries have long utilized our analytical and research capabilities, and about half of our work is pharma-related,” says David Dowell, Ph.D., president of Chemir Analytical Services. “We welcome Bob’s depth of knowledge and experience in maintaining GMP compliance in FDA regulated studies as we further expand our service offerings to the pharma industry.”

Dr. Lima formerly directed analytical services at Analytical Biochemistry (ABC) Laboratories, as well as managed drug development projects for Allergan Pharmaceuticals and Procter & Gamble Pharmaceuticals.